Article

Daily Medication Pearl: Armodafinil (Nuvigil)

Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents.

Medication Pearl of the Day: Armodafinil (Nuvigil)

Indication: Armodafinil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).

Insight:

  • Dosing: OSA or narcolepsy 150 mg to 250 mg once a day in the morning.
  • Dosage forms: Tablets 50 mg, 150 mg, 200 mg, and 250 mg.
  • Adverse events: Most common adverse reactions (³5%) are headache, nausea, dizziness, and insomnia.
  • Mechanism of action: Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents, including amphetamine and methylphenidate, although their pharmacologic profile is not identical to that of the sympathomimetic amines.
  • Manufacturer: Teva Pharma

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com